The circadian rhythm as therapeutic target in inflammatory bowel disease
Journal of the Canadian Association of Gastroenterology · 21.02.2025 · 8 (Supplement_2) · S27-S35
DOI: 10.1093/jcag/gwae027 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the Canadian Association of Gastroenterology, online erschienen am 13.08.2024. Verfasst von Zoë Post und 2 weiteren Autor:innen. Beteiligte Einrichtung: Rush University Medical Center, Department of Internal Medicine, Division of Digestive Diseases and Nutrition, Chicago, IL 60612, United States. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
The primary objectives of the management of patients with inflammatory bowel disease (IBD) are to prevent IBD flares, prevent/delay disease progression and improve patients’ quality of life. To this end, one needs to identify risk factor(s) associated with flare-ups and disease progression. We posit that disruption of circadian rhythms is one of the key factors that is associated with risk of flare-up and disease progression. This hypothesis is based on published studies that show: (1) The circadian rhythm regulates many biological processes including multiple IBD-relevant biological processes that are critical in inflammatory/immune processes such as environment/microbe interaction, microbe/host interaction, intestinal barrier integrity and mucosal immunity—all central in the pathogenesis of IBD, and (2) Circadian machinery is the primary tool for the host to interact with the environment. Circadian misalignment results in a loss of preparedness of the host to respond and adjust to the environmental changes that could make the host more vulnerable to IBD flare-ups. In this review, we first provide an overview of circadian rhythms and its role in healthy and disease states. Then we present data to support our hypothesis that: (1) IBD patients have disrupted circadian rhythms (“social jet lag”) and (2) circadian misalignment and associated disrupted sleep decreases the resiliency of IBD patients resulting in microbiota dysbiosis, more disrupted intestinal barrier integrity and a more aggressive disease phenotype. We also show that circadian-directed interventions have a potential to mitigate the deleterious impact of disrupted circadian and improve IBD disease course.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Rush University Medical Center, Department of Internal Medicine, Division of Digestive Diseases and Nutrition, Chicago, IL 60612, United States.
- Rush Center for Integrated Microbiome and Chronobiology Research (CIMCR), Rush University Medical Center, Chicago, IL 60612, United States.
- Rush University, Department of Physiology, Anatomy and Cell Biology, Chicago, IL 60612, United States.
ORCID-Profile: Zoë Post
Förderung
- NCI NIH HHS
- NCATS NIH HHS
Zitieren
APA
Post, Z., Zilberstein, N. F., & Keshavarzian, A. (2025). The circadian rhythm as therapeutic target in inflammatory bowel disease. Journal of the Canadian Association of Gastroenterology, 8(Supplement_2), S27-S35. https://doi.org/10.1093/jcag/gwae027
Vancouver
Post Z, Zilberstein NF, Keshavarzian A. The circadian rhythm as therapeutic target in inflammatory bowel disease. Journal of the Canadian Association of Gastroenterology. 2025;8(Supplement_2):S27-S35. doi:10.1093/jcag/gwae027
BibTeX
@article{Post2025,
author = {Post, Zoë and Zilberstein, Netanel F and Keshavarzian, Ali},
title = {The circadian rhythm as therapeutic target in inflammatory bowel disease},
journal = {Journal of the Canadian Association of Gastroenterology},
year = {2025},
volume = {8},
number = {Supplement_2},
pages = {S27--S35},
doi = {10.1093/jcag/gwae027}
}
EUVIMED